LicianPro

IKT holders · CITADEL ADVISORS LLC 13F · IKT stock

CITADEL ADVISORS LLC Inhibikase Therapeutics Inc (IKT) 13F holding

CITADEL ADVISORS LLC reported 1,102,585 IKT shares valued at $1.9M as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

This is the newest IKT 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the IKT holders table.

IKT reports from CITADEL ADVISORS LLC · SEC Form 13F
ReportSharesValueClass
2026-03-311,102,585$1.9MCOM NEW
2025-12-311,243,630$2.5MCOM NEW
2025-09-3071,670$116.1KCOM NEW

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.